Трудности регистрации медицинских изделий в ЕАЭС
March 26, 2024PIL Readability Testing is Mandatory in EAEU
How to comply with all applicable EAEU regulations and ensure effective PIL Readability Testing? To conduct PIL Testing, you should be familiar with the EAEU rules and have appropriate experience in local markets.
Over the years Inpharmatis has obtained extensive experience in conducting successful Readability User Testing according to the EAEU rules.
Inpharmatis is an international consulting company with more than 15 years of experience in EAEU, CIS and EU markets in the field of regulatory services for pharmaceutical companies.
We have the capabilities to support you with effective PIL Testing: |
✔️ Extensive local expertise and dedicated service |
✔️ Guaranteed acceptance across the EAEU requirements |
✔️ Bridging studies to reduce clients’ costs |
✔️ Highly qualified multilanguage team in EAEU |
Challenges of Medical Devices Registration in the EAEU
March 26, 2024Новые поправки к Федеральному закону "Об обращении лекарственных средств" в России
March 13, 2024New Amendments in Federal Law “On Circulation of Medicines” in Russia
March 13, 2024В Грузии фармацевтические компании, не предоставившие сертификат GMP, столкнулись с новыми рисками
February 28, 2024In Georgia, Pharmaceutical Companies That Have Not Provided a GMP Certificate are Facing New Risks
February 28, 2024Получение GMP сертификата ЕАЭС обязательная процедура
February 21, 2024EAEU GMP Certificate is Mandatory
February 20, 2024Полина Домбуре, директор Inpharmatis, приняла участие в TOPRA Summit 2024
February 19, 2024Dr. Polina Dombure, Inpharmatis CEO, Participated in TOPRA Summit 2024
February 19, 2024